{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:26:03Z","timestamp":1792599963632,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004866","name":"National Research Program for Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["103-2325-B-002-033"],"award-info":[{"award-number":["103-2325-B-002-033"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jfma.2021.06.015","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T09:35:05Z","timestamp":1625736905000},"page":"643-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients"],"prefix":"10.1016","volume":"121","author":[{"given":"Shang-Yi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Hsia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jih-Luh","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-698X","authenticated-orcid":false,"given":"Wen-Chien","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Sheng","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei-Fang","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.06.015_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","article-title":"Proteoglycan form and function: a comprehensive nomenclature of proteoglycans","volume":"42","author":"Iozzo","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jfma.2021.06.015_bib2","doi-asserted-by":"crossref","first-page":"15633","DOI":"10.1073\/pnas.0402976101","article-title":"Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan","volume":"101","author":"Scott","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jfma.2021.06.015_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2007-11-124164","article-title":"Role of decorin in the antimyeloma effects of osteoblasts","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2021.06.015_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ajpath.2012.04.029","article-title":"Decorin-a guardian from the matrix","volume":"181","author":"Neill","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jfma.2021.06.015_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0945-053X(98)90121-4","article-title":"Leucine-rich repeat glycoproteins of the extracellular matrix","volume":"17","author":"Hocking","year":"1998","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jfma.2021.06.015_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.13963","article-title":"Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology","volume":"284","author":"Schaefer","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.jfma.2021.06.015_bib7","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.271.31.18961","article-title":"Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases","volume":"271","author":"De Luca","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfma.2021.06.015_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045559","article-title":"Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model","volume":"7","author":"Buraschi","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2021.06.015_bib9","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1074\/jbc.M113.512566","article-title":"Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 (PGC-1\u03b1) and mitostatin","volume":"289","author":"Neill","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfma.2021.06.015_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addr.2015.10.016","article-title":"Decorin as a multivalent therapeutic agent against cancer","volume":"97","author":"Neill","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jfma.2021.06.015_bib11","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/carcin\/bgn141","article-title":"Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation","volume":"29","author":"Bi","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jfma.2021.06.015_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.matbio.2013.11.004","article-title":"Decorin deficiency promotes hepatic carcinogenesis","volume":"35","author":"Horvath","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jfma.2021.06.015_bib13","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1073\/pnas.96.6.3092","article-title":"Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis","volume":"96","author":"Iozzo","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jfma.2021.06.015_bib14","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1074\/jbc.M111.283499","article-title":"Decorin antagonizes the angiogenic network. Concurrent inhibition of Met, hipoxia inducible factor-1a and vascular endothelial growth factor A and induction of thrombospondin-1 and TIMP3","volume":"287","author":"Neill","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfma.2021.06.015_bib15","doi-asserted-by":"crossref","first-page":"654765","DOI":"10.1155\/2015\/654765","article-title":"Decorin: a growth factor antagonist for tumor growth inhibition","volume":"2015","author":"Jarvinen","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jfma.2021.06.015_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.matbio.2016.09.009","article-title":"Decorin interacting network: a comprehensive analysis of decorin-binding partners and their versatile functions","volume":"55","author":"Gubbiotti","year":"2016","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jfma.2021.06.015_bib17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1586\/14737159.2015.1046436","article-title":"MET\/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?","volume":"15","author":"Gambella","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jfma.2021.06.015_bib18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2021.06.015_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2559.2011.04112.x","article-title":"Immunohistochemical analysis of hepatocytes growth factor and c-Met in plasma cell disease","volume":"60","author":"Wader","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.jfma.2021.06.015_bib20","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1158\/1078-0432.CCR-14-0847","article-title":"A HGF\/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target","volume":"20","author":"Ferrucci","year":"2014","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.jfma.2021.06.015_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/bjh.12719","article-title":"MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients","volume":"164","author":"Rocci","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jfma.2021.06.015_bib22","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V88.10.3998.bloodjournal88103998","article-title":"Hepatocyte growth factor and its receptor c-met in multiple myeloma","volume":"88","author":"Borset","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2021.06.015_bib23","first-page":"603","article-title":"Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene","volume":"9","author":"Purdie","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.jfma.2021.06.015_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1083\/jcb.200901129","article-title":"Decorin is a novel antagonistic ligand of the Met receptor","volume":"185","author":"Goldoni","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jfma.2021.06.015_bib25","doi-asserted-by":"crossref","first-page":"42075","DOI":"10.1074\/jbc.M110.172841","article-title":"Decorin antagonizes Met receptor activity and downregulates \u03b2-catenin and Myc levels","volume":"285","author":"Buraschi","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfma.2021.06.015_bib26","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1021\/acs.biochem.5b00653","article-title":"Decoding the matrix: instructive roles of proteoglycan receptors","volume":"54","author":"Neill","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.jfma.2021.06.015_bib27","doi-asserted-by":"crossref","first-page":"62490","DOI":"10.18632\/oncotarget.11519","article-title":"Soluble PD-L1: a biomarker to predict progression of autologous transplantation in patients with multiple myeloma","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jfma.2021.06.015_bib28","article-title":"Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - a retrospective study","volume":"10","author":"Huang","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2021.06.015_bib29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International Myeloma Working Group. International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.jfma.2021.06.015_bib30","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","article-title":"International myeloma workshop consensus panel 1. Consensus recommendations for the uniform reporting of clinical trials: report of the international myeloma workshop consensus panel 1","volume":"117","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2021.06.015_bib31","article-title":"The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapy","volume":"9","author":"Lin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2021.06.015_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0002-9440(10)63162-8","article-title":"Nonirradiated NOD\/SCID-human chimeric animal model for primary human multiple myeloma: a potential in\u00a0vivo culture system","volume":"164","author":"Huang","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jfma.2021.06.015_bib33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/ejh.12125","article-title":"Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration","volume":"91","author":"Kristensen","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jfma.2021.06.015_bib34","first-page":"6192","article-title":"In\u00a0vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin","volume":"59","author":"Nash","year":"1999","journal-title":"Canc Res"},{"key":"10.1016\/j.jfma.2021.06.015_bib35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbrc.2004.08.008","article-title":"Pancreatic tumor cells influence the composition of the extracellular matrix","volume":"322","author":"Koninger","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jfma.2021.06.015_bib36","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4161\/cc.20316","article-title":"Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation","volume":"11","author":"Moreth","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jfma.2021.06.015_bib37","doi-asserted-by":"crossref","first-page":"ra75","DOI":"10.1126\/scisignal.2001868","article-title":"Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21","volume":"4","author":"Merline","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.jfma.2021.06.015_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.46582\/jsrm.1101004","article-title":"Human mesenchymal stem cells stimulate EaHy926 endothelial cell migration: combined proteomic and in\u00a0vitro analysis of the influence of donor-donor variability","volume":"11","author":"Walter","year":"2015","journal-title":"J Stem Cells Regen Med"},{"key":"10.1016\/j.jfma.2021.06.015_bib39","article-title":"Oncosuppressive functions of decorin","volume":"2","author":"Neill","year":"2015","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.jfma.2021.06.015_bib40","first-page":"207","article-title":"Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer","volume":"9","author":"Troup","year":"2003","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.jfma.2021.06.015_bib41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jso.20745","article-title":"Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissuetumors","volume":"96","author":"Matsumine","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jfma.2021.06.015_bib42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ijc.21823","article-title":"Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer","volume":"119","author":"Newton","year":"2006","journal-title":"Int J Canc"},{"key":"10.1016\/j.jfma.2021.06.015_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-0609.2010.01417.x","article-title":"Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis","volume":"84","author":"Lund","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jfma.2021.06.015_bib44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jbmr.2371","article-title":"Role of decorin in multiple myeloma (MM) bone marrow microenvironment","volume":"30","author":"Nemani","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2021.06.015_bib45","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1073\/pnas.92.15.7016","article-title":"De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells","volume":"92","author":"Santra","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jfma.2021.06.015_bib46","first-page":"1533","article-title":"Decorin suppresses lung metastases of murine osteosarcoma","volume":"19","author":"Shintani","year":"2008","journal-title":"Oncol Rep"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621002953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621002953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:35:46Z","timestamp":1777592146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621002953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0929664621002953"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.06.015","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}